496 related articles for article (PubMed ID: 11938420)
1. The prevalence of hepatitis B core antibody positivity in donors for liver transplantation in Saudi Arabia.
Al-Sebayel MI; Khalaf HA; Ramirez CG
Saudi Med J; 2002 Mar; 23(3):298-300. PubMed ID: 11938420
[TBL] [Abstract][Full Text] [Related]
2. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia.
El Beltagy KE; Al Balawi IA; Almuneef M; Memish ZA
Int J Infect Dis; 2008 Sep; 12(5):495-9. PubMed ID: 18400539
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
El-Hazmi MM
Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
[TBL] [Abstract][Full Text] [Related]
5. The status of cadaveric organ donation for liver transplantation in Saudi Arabia.
Al-Sebayel MI
Saudi Med J; 2002 May; 23(5):509-12. PubMed ID: 12070569
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of antibody to hepatitis B core antigen screening among blood donors in Eastern Saudi Arabia. Need to replace the test by HBV DNA testing.
Panhotra BR; Al-Bahrani A; Ul-Hassan Z
Saudi Med J; 2005 Feb; 26(2):270-3. PubMed ID: 15770304
[TBL] [Abstract][Full Text] [Related]
7. The decline of hepatitis B viral infection in South-Western Saudi Arabia.
Ayoola AE; Tobaigy MS; Gadour MO; Ahmad BS; Hamza MK; Ageel AM
Saudi Med J; 2003 Sep; 24(9):991-5. PubMed ID: 12973485
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis B virus markers among drug-dependent patients in Jeddah Saudi Arabia.
Njoh J
East Afr Med J; 1995 Aug; 72(8):490-1. PubMed ID: 7588140
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis B and C and blood donors.
Mehdi SR; Pophali A; Al-Abdul Rahim KA
Saudi Med J; 2000 Oct; 21(10):942-4. PubMed ID: 11369958
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001.
Bashawri LA; Fawaz NA; Ahmad MS; Qadi AA; Almawi WY
Clin Lab Haematol; 2004 Jun; 26(3):225-8. PubMed ID: 15163322
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation with allografts from hepatitis B core antibody-positive donors: a new approach.
Fábrega E; García-Suarez C; Guerra A; Orive A; Casafont F; Crespo J; Pons-Romero F
Liver Transpl; 2003 Sep; 9(9):916-20. PubMed ID: 12942452
[TBL] [Abstract][Full Text] [Related]
12. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
Yu L; Koepsell T; Manhart L; Ioannou G
Liver Transpl; 2009 Oct; 15(10):1343-50. PubMed ID: 19790164
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
[TBL] [Abstract][Full Text] [Related]
14. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients.
Veroux M; Puliatti C; Gagliano M; Cappello D; Macarone M; Vizcarra D; Spataro M; Di Mare M; Ginevra N; Veroux P
Transplant Proc; 2005; 37(6):2574-5. PubMed ID: 16182748
[TBL] [Abstract][Full Text] [Related]
15. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
Ghisetti V; Marzano A; Zamboni F; Barbui A; Franchello A; Gaia S; Marchiaro G; Salizzoni M; Rizzetto M
Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B core antibody-positive grafts: recipient's risk.
de Villa VH; Chen YS; Chen CL
Transplantation; 2003 Feb; 75(3 Suppl):S49-53. PubMed ID: 12589141
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
[TBL] [Abstract][Full Text] [Related]
18. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
19. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
20. Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study.
De Feo TM; Poli F; Mozzi F; Moretti MP; Scalamogna M;
Transplant Proc; 2005 Mar; 37(2):1238-9. PubMed ID: 15848681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
